Bora Pharmaceuticals expanded biologics manufacturing capabilities in Rockville, Maryland.
Public source
Publisher name
Public post
As pharmaceutical companies navigate increasingly complex development, technology transfer, and commercial supply needs, having access to the right capacity at the right…
Company
Bora Pharmaceuticals
A premier international CDMO, making success more certain.
- Industry
- Pharmaceutical Manufacturing
- Location
- Taipei, TW
- Company size
- 501–1,000 employees
About Bora Pharmaceuticals
Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in complex oral solid dose, liquids, semi-solids, opthalmics, biologics, and sterile injectable products. We provide early phase clinical through to commercial manufacturing with full packaging capabilities to biopharma companies worldwide. Bora owns and operates in ten state-of-the-art CGMP manufacturing facilities across Asia and North America – delivering to more than 100 markets around the world. Our sites have the highest international standards for manufacturing, packaging, R&D and analytical testing. As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. That's why, when you choose Bora - we make success more certain by following Bora’s 5Ps – Promises, Partnerships, Pride, People, and Progress. These 5 principles are Bora’s Pledge to our customers. Follow us to find out more and keep up to date with Bora Pharmaceuticals.
See moreLatest activity
Latest activity from Bora Pharmaceuticals
12 signals
Operations & Supply
Bora Pharmaceuticals operates an U.S. manufacturing network across its pharmaceutical manufacturing capabilities.
Presence & Recognition
Bora Pharmaceuticals is hosting a stand at 12C49 to help bring products to the market.
Presence & Recognition
Bora Pharmaceuticals is exhibiting at CPHI Milan in Booth #12C49 in Hall 12
Discover more
Similar signals
Similar public activity from other companies.
Operations & Supply
Afton Scientific, LLC
Afton Scientific, LLC announced that 4 new high-speed isolator filling lines are coming to support clients' projects.
Operations & Supply
Curia
Curia announced the grand opening of its expanded Albuquerque, New Mexico campus, a $200 million investment that strengthens domestic sterile fill-finish manufacturing capacity.
Operations & Supply
LOTTE Biologics
LOTTE Biologics established technical foundation for scaling and transferring client processes into 15 kL manufacturing at Songdo Bio Campus.
Operations & Supply
Avara Pharmaceutical Services
Avara Pharmaceutical Services supports sponsors with sensitive, small-batch programs at its sterile fill-finish facility in Liscate, Italy.
Operations & Supply
August Bioservices, LLC